^
Association details:
| Biomarker: | BRAF G469R |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | sorafenib (Multi-tyrosine kinase inhibitor, pan-RAF inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation
Excerpt:
...a case report of a patient with NSCLC and the BRAF G469R mutation who showed a dramatic response to sorafenib.
DOI:
10.1097/CAD.0000000000000277
